Research Topics
| E B DamSummaryAffiliation: Nordic Bioscience Country: Denmark Publications
| Collaborators
|
Detail Information
Publications
Automatic morphometric cartilage quantification in the medial tibial plateau from MRI for osteoarthritis gradingE B Dam
Image Group, IT University of Copenhagen
Osteoarthritis Cartilage 15:808-18. 2007..To evaluate whether a novel, fully automatic, morphometric cartilage quantification framework is suitable for assessing level of knee osteoarthritis (OA) in clinical trials...
Should subchondral bone turnover be targeted when treating osteoarthritis?M A Karsdal
Nordic Bioscience A S, Herlev, Denmark
Osteoarthritis Cartilage 16:638-46. 2008..We speculate whether a treatment for OA would be possible without targeting the bone compartment?..
Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRIE B Dam
Nordic Bioscience A S, Herlev Hovedgade 207, DK 2730 Herlev, Denmark
Osteoarthritis Cartilage 17:384-9. 2009..We investigated the longitudinal interrelationship between CTX-II and knee cartilage volume quantified from magnetic resonance imaging (MRI)...
Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug developmentM A Karsdal
Nordic Bioscience A S, Herlev Hovedgade 207, Herlev, Denmark
Biomarkers 14:181-202. 2009..Biochemical markers of tissue degradation may provide optimal tools, which in combination with other techniques, prove essential to drug discovery and development...
Separation of healthy and early osteoarthritis by automatic quantification of cartilage homogeneityA A Qazi
Image Group, University of Copenhagen, Denmark
Osteoarthritis Cartilage 15:1199-206. 2007..As water distribution is detectable by MRI, the aim of this study was to investigate cartilage homogeneity visualized by MRI related to water distribution, as a potential very early marker for early detection of knee osteoarthritis (OA)...
